Please complete the CAPTCHA to continue
@biophytis.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Pierre J. Dilda is listed as Chief Scientific Officer, IP Director at Biophytis - New Therapeutics for aging diseases, based in Greater Paris Metropolitan Region, France, France. AeroLeads shows a work email signal at biophytis.com and a matched LinkedIn profile for Pierre J. Dilda.
Pierre J. Dilda previously worked as VP Research at Biophytis - New Therapeutics For Aging Diseases and Director of Research at Biophytis - New Therapeutics For Aging Diseases. Pierre J. Dilda holds Master 2 Degree, Intellectual Property Strategy And Innovation from University Of Strasbourg.
This section adds company-level context without repeating Pierre J. Dilda's masked contact details.
AeroLeads found 1 current-domain work email signal for Pierre J. Dilda. Compare company email patterns before reaching out.
Chief Scientific OfficerTwenty five years of experience in investigational new drug characterization and development in industry, biotech and academic environments.PhD in Pharmacology.Demonstrated experience working in multidisciplinary groups across multiple organization and operative units.Involvement in strategic plans’ definition and in the management of preclinical, non-clinical and pharmaceutical development of new drug candidates. In charge innovation and intellectual property protection: patentability evaluation (novelty & inventive steps), patent writing and defence.Management of preclinical research & development projects and teams of researchers and technicians. Coordination of “hit to lead” process from screening to the identification of mode of action and translational research.Executice Committee member
Listed skills include Drug Discovery, Cancer, Biochemistry, Pharmacology, and 14 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Paris, Ile De France, FR
Strategy planning and decision making in preclinical research of new drug candidates for the treatment of age-related diseases. Management of research projects and teams of researchers. Coordination of processes from screening to the identification of mode of action and translational research. In charge of scientific communication and intellectual property.
Sydney, New South Wales (NSW), AU
Design and pharmacological characterization of anti-cancer drugs.- From basic research to clinic. Two drugs taken from bench to bedside: GSAO entered Phase I/IIa in 2008 and PENAO entered Phase I/IIa in 2012.- Publications and patents. Publications in the 3 top cancer biology journals such as Cancer Cell (IF=24.9), the Journal of the National Cancer.
Rueil-Malmaison, Île-de-France, FR
Design and characterization of new HIV non-nucleosidic RT inhibitors. HIV pharmacology and characterization of new and potent NNRTIs.
Rueil-Malmaison, Île-de-France, FR
Design of new anticancer and antiviral compounds and coordination of the in vitro screening. Global coordination of in vitro biological evaluations.
Rueil-Malmaison, Île-de-France, FR
Study of HIV-1 protease natural and induced variability. Conception by molecular modeling of a new generation of non-competitive inhibitors
Paris, France, FR
Scientist in the laboratory of Neurovirology. Development of a quantitative PCR by competition on DNA of PBMC from macaques infected by SIV. Research of reversion in macaques vaccinated by delta-nefSIV.
Quick answers generated from the profile data available on this page.
Pierre J. Dilda works for Biophytis - New Therapeutics for aging diseases.
Pierre J. Dilda is listed as Chief Scientific Officer, IP Director at Biophytis - New Therapeutics for aging diseases.
AeroLeads has found 1 work email signal at @biophytis.com for Pierre J. Dilda at Biophytis - New Therapeutics for aging diseases.
Pierre J. Dilda is based in Greater Paris Metropolitan Region, France, France while working with Biophytis - New Therapeutics for aging diseases.
Pierre J. Dilda has worked for Biophytis - New Therapeutics For Aging Diseases, Unsw, Mayoly Spindler Laboratories, and Cea - Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives.
You can use AeroLeads to view verified contact signals for Pierre J. Dilda at Biophytis - New Therapeutics for aging diseases, including work email, phone, and LinkedIn data when available.
Pierre J. Dilda holds Master 2 Degree, Intellectual Property Strategy And Innovation from University Of Strasbourg.
Pierre J. Dilda is listed with skills including Drug Discovery, Cancer, Biochemistry, Pharmacology, Pharmaceutical Industry, Drug Design, Cell Biology, and Cell Culture.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts